LogicBio Therapeutics, Inc. Deferred Revenue (Non-Current)
LogicBio Therapeutics, Inc. had Deferred Revenue (Non-Current) of $1.09 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2022-11-14
- 2022-09-30: Deferred Revenue, Noncurrent $1.09M.
- 2022-06-30: Deferred Revenue, Noncurrent $1.73M.
- 2022-03-31: Deferred Revenue, Noncurrent $2.86M.
- 2021-12-31: Deferred Revenue, Noncurrent $3.73M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2022-09-30 | $1.09M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.73M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.86M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $3.73M 10-Q · filed 2022-11-14 |
| 2021-09-30 | $5.90M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $7.97M 10-Q · filed 2021-08-09 |